medical device investing Chembio Diagnostics Announces Agreement with Perseus Science to Advance Point-of-Care Concussion Test
medical device investing Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases
medical device investing Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results
GoldInxs Mining Corp. Closes Initial Public Offering and Announces Listing on the TSX Venture Exchange
Ni-Co Énergie annonce des résultats d'échantillons choisis à Kremer-2 titrant jusqu'à 1,21 % Ni, 0,14 % Cu et 0,10 % Co; 11 des 33 échantillons de Kremer-2 ont retourné plus de 0,5 % Ni.
